Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of June 2025. The report specifically details a transaction in the company's own shares executed under its share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity and capital structure updates.
- Shares Purchased: 1,011,111 ordinary shares
- Purchase Date: June 19, 2025
- Price Range: 382.80p (Low) to 384.90p (High)
- Volume Weighted Average Price: 383.82p
- Post-Transaction Share Capital: 8,992,573,595 ordinary shares
- Treasury Shares: 4,080,205
- Voting Shares Outstanding: 8,988,493,390
Material Changes
The primary material change is the reduction in the number of shares with voting rights following the cancellation of the purchased shares. The filing does not provide comparative financial data against prior periods.
Outlook, Risks, and Management Commentary
Management commentary is limited to the execution of the buyback programme. The filing includes a standard disclaimer that the announcement does not constitute an offer or solicitation of securities. No specific guidance, risks, or contingencies regarding future operations are detailed in this specific report.
Key Facts for Investor Verification
- Verify the total volume of shares repurchased under the March 2025 buyback programme to date.
- Confirm the current market price relative to the 383.82p average purchase price.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular transaction data.
- Monitor the reduction in voting shares to assess potential impacts on earnings per share (EPS) in future financial reports.